Editorial: Emerging technologies for viability enumeration of live microorganisms
- PMID: 39886210
- PMCID: PMC11780490
- DOI: 10.3389/fmicb.2024.1546438
Editorial: Emerging technologies for viability enumeration of live microorganisms
Keywords: beneficial organisms; emerging technologies; live biotherapeutic products; live microorganisms; microbiome products; potency; probiotics; viability enumeration.
Conflict of interest statement
HS is employed by Purity-IQ Inc. EB is employed by University of Pretoria. BK is employed by United States Pharmacopeia. MP is employed by Probiotical Research S.r.l. CV is employed by Probi AB. JS is employed by Eurofins Microbiology Laboratory, Inc. This Editing Team recused themselves in any instance where a conflict of interest might be construed. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Comment on
- Editorial on the Research Topic Emerging technologies for viability enumeration of live microorganisms
References
-
- Chang Y., Wang K., Zhou M., Miao Y., Wu X., Chen Q., et al. . (2024). Bioencapsulation of probiotics with self-assembled DNA capsules for the treatment of inflammatory bowel diseases. Chem. Engin. J. 499:155527. 10.1016/j.cej.2024.155527 - DOI
Publication types
LinkOut - more resources
Full Text Sources